Journal article
Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study
- Abstract:
-
Study question: How safe is live attenuated influenza vaccine (LAIV), which contains egg protein, in young people with egg allergy? Methods: In this open label, phase IV intervention study, 779 young people (2-18 years) with egg allergy were recruited from 30 UK allergy centres and immunised with LAIV. The cohort included 270 (34.7%) young people with previous anaphylaxis to egg, of whom 157 (20.1%) had experienced respiratory and/or cardiovascular symptoms.... Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
+ Department of Health
More from this funder
Grant:
National Vaccine Evaluation Consortium, 039/0031
Bibliographic Details
- Publisher:
- BMJ Publishing Group Publisher's website
- Journal:
- BMJ Journal website
- Volume:
- 351
- Article number:
- h6291
- Publication date:
- 2015-01-01
- Acceptance date:
- 2015-11-05
- DOI:
- EISSN:
-
1756-1833
- Source identifiers:
-
610249
Item Description
- Pubs id:
-
pubs:610249
- UUID:
-
uuid:0094eee6-3cb2-406c-95ba-08a11e07d618
- Local pid:
- pubs:610249
- Deposit date:
- 2016-03-16
Terms of use
- Copyright holder:
- BMJ Publishing Group Ltd
- Copyright date:
- 2015
- Notes:
- This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record